{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T13:50:29Z","timestamp":1785246629918,"version":"3.55.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00347-023-01876-8","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T18:32:17Z","timestamp":1684866737000},"page":"588-596","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sp\u00e4tfolgen der Fr\u00fchgeborenenretinopathie im Kindesalter","Late sequelae of retinopathy of prematurity in infancy"],"prefix":"10.1007","volume":"120","author":[{"given":"Jeany Q.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M.","family":"Pfeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim U.","family":"Krohne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,23]]},"reference":[{"key":"1876_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3928\/01913913-20190501-01","volume":"56","author":"R Al-Taie","year":"2019","unstructured":"Al-Taie R, Simkin SK, Dou\u00e7et E et al (2019) Persistent avascular retina in infants with a history of type 2 retinopathy of prematurity: to treat or not to treat? J Pediatr Ophthalmol Strabism 56:222\u2013228","journal-title":"J Pediatr Ophthalmol Strabism"},{"key":"1876_CR2","doi-asserted-by":"crossref","unstructured":"Alharkan DH, Kahtani ES, Gikandi PW et al (2014) Vitreous hemorrhage in pediatric age group. J Ophthalmol 201(4)","DOI":"10.1155\/2014\/497083"},{"key":"1876_CR3","doi-asserted-by":"publisher","first-page":"4666","DOI":"10.1167\/iovs.12-11241","volume":"54","author":"W Bowl","year":"2013","unstructured":"Bowl W, Lorenz B, J\u00e4ger M et al (2013) Improving detection of mild loss of retinal light increment sensitivity at the posterior pole with the microperimeter MP1. Investig Ophthalmol Vis Sci 54:4666\u20134674","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1876_CR4","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1167\/iovs.18-24892","volume":"60","author":"W Bowl","year":"2019","unstructured":"Bowl W, Raoof S, Lorenz B et al (2019) Cone-mediated function correlates to altered foveal morphology in preterm-born children at school age. Investig Ophthalmol Vis Sci 60:1614\u20131620","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1876_CR5","first-page":"OCT235\u2013OCT241","volume":"57","author":"W Bowl","year":"2016","unstructured":"Bowl W, Stieger K, Bokun M et al (2016) OCT-based macular structure-function correlation in dependence on birth weight and gestational age\u2014the Giessen Long-Term ROP Study. Investig Ophthalmol Vis Sci 57:OCT235\u2013OCT241","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1876_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1001\/archopht.116.3.329","volume":"116","author":"DL Bremer","year":"1998","unstructured":"Bremer DL, Palmer EA, Fellows RR et al (1998) Strabismus in premature infants in the first year of life. Arch Ophthalmol 116:329\u2013333","journal-title":"Arch Ophthalmol"},{"key":"1876_CR7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jaapos.2012.06.011","volume":"16","author":"DL Bremer","year":"2012","unstructured":"Bremer DL, Rogers DL, Good WV et al (2012) Glaucoma in the Early Treatment for Retinopathy of Prematurity (ETROP) study. J Am Assoc Pediatr Ophthalmol Strabism 16:449\u2013452","journal-title":"J Am Assoc Pediatr Ophthalmol Strabism"},{"key":"1876_CR8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/BF00917831","volume":"18","author":"MM Brown","year":"1994","unstructured":"Brown MM, Brown GC, Duker JS et al (1994) Exudative retinopathy of adults: a late sequela of retinopathy of prematurity. Int Ophthalmol 18:281\u2013285","journal-title":"Int Ophthalmol"},{"key":"1876_CR9","doi-asserted-by":"publisher","first-page":"e223972","DOI":"10.1371\/journal.pone.0223972","volume":"14","author":"Y\u2011S Chang","year":"2019","unstructured":"Chang Y\u2011S, Chen Y\u2011T, Lai T\u2011T et al (2019) Involution of retinopathy of prematurity and neurodevelopmental outcomes after intravitreal bevacizumab treatment. PLoS One 14:e223972","journal-title":"PLoS One"},{"key":"1876_CR10","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1167\/iovs.10-5234","volume":"51","author":"TC Chen","year":"2010","unstructured":"Chen\u00a0TC, Tsai\u00a0TH, Shih\u00a0YF et al (2010) Long-term evaluation of refractive status and optical components in eyes of children born prematurely. Investig Ophthalmol Vis Sci 51:6140\u20136148","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1876_CR11","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.ophtha.2021.05.031","volume":"128","author":"MF Chiang","year":"2021","unstructured":"Chiang MF, Quinn GE, Fielder AR et al (2021) International classification of retinopathy of prematurity. Ophthalmology 128:e51\u2013e68","journal-title":"Ophthalmology"},{"key":"1876_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1167\/tvst.9.8.43","volume":"9","author":"M Fidler","year":"2020","unstructured":"Fidler M, Fleck BW, Stahl A et al (2020) Ranibizumab population pharmacokinetics and free VEGF pharmacodynamics in preterm infants with retinopathy of prematurity in the RAINBOW trial. Trans Vis Sci Technol 9:43\u201343","journal-title":"Trans Vis Sci Technol"},{"key":"1876_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12886-017-0605-1","volume":"17","author":"A Fie\u00df","year":"2017","unstructured":"Fie\u00df A, K\u00f6lb-Keerl R, Schuster AK et al (2017) Prevalence and associated factors of strabismus in former preterm and full-term infants between 4 and 10 Years of age. BMC Ophthalmol 17:1\u20139","journal-title":"BMC Ophthalmol"},{"key":"1876_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00347-023-01873-x","author":"A Fie\u00df","year":"2023","unstructured":"Fie\u00df A (2023) Fr\u00fchgeburtlichkeit und deren okul\u00e4re Auswirkungen. Ophthalmologie. https:\/\/doi.org\/10.1007\/s00347-023-01873-x","journal-title":"Auswirkungen. Ophthalmologie."},{"key":"1876_CR15","first-page":"4177","volume":"53","author":"HC Fledelius","year":"2012","unstructured":"Fledelius HC, Fledelius CJIO, Science V (2012) Eye size in threshold retinopathy of prematurity, based on a Danish preterm infant series: early axial eye growth, pre-and postnatal aspects. Inv Ophthalmol Vis Sci 53:4177\u20134184","journal-title":"Sci"},{"key":"1876_CR16","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1001\/jamaophthalmol.2014.2772","volume":"132","author":"MM Geloneck","year":"2014","unstructured":"Geloneck MM, Chuang AZ, Clark WL et al (2014) Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial. JAMA Ophthalmol 132:1327\u20131333","journal-title":"JAMA Ophthalmol"},{"key":"1876_CR17","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1242\/dev.126.6.1149","volume":"126","author":"H\u2011P Gerber","year":"1999","unstructured":"Gerber H\u2011P, Hillan KJ, Ryan AM et al (1999) VEGF is required for growth and survival in neonatal mice. Development 126:1149\u20131159","journal-title":"Development"},{"key":"1876_CR18","first-page":"227","volume":"79","author":"C Gilbert","year":"2001","unstructured":"Gilbert C, Foster AJBOTWHO (2001) Childhood blindness in the context of VISION 2020: the right to sight. Bull WHO 79:227\u2013232","journal-title":"Bull WHO"},{"key":"1876_CR19","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/archopht.1989.01070020079034","volume":"107","author":"CM Greven","year":"1989","unstructured":"Greven CM, Tasman WJa O (1989) Rhegmatogenous retinal detachment following cryotherapy in retinopathy of prematurity. Arch Ophthalmol 107:1017\u20131018","journal-title":"Arch Ophthalmol"},{"key":"1876_CR20","first-page":"602","volume":"4","author":"AE Hamad","year":"2020","unstructured":"Hamad AE, Moinuddin O, Blair MP et al (2020) Late-onset retinal findings and complications in untreated retinopathy of prematurity. Ophthalmol Retina 4:602\u2013612","journal-title":"Retina"},{"key":"1876_CR21","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0161-6420(79)35437-9","volume":"86","author":"HM Hittner","year":"1979","unstructured":"Hittner HM, Rhodes LM, Mcpherson A (1979) Anterior segment abnormalities in cicatricial retinopathy of prematurity. Ophthalmology 86:803\u2013816","journal-title":"Ophthalmology"},{"key":"1876_CR22","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1111\/j.1755-3768.2012.02469.x","volume":"91","author":"R Hoerster","year":"2012","unstructured":"Hoerster R, Muether P, Dahlke C et al (2012) Serum concentrations of vascular endothelial growth factor in an infant treated with ranibizumab for retinopathy of prematurity. Acta Ophthalmol 91:e74\u2013e75","journal-title":"Acta Ophthalmol"},{"key":"1876_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-99269-x","volume":"12","author":"EH Hong","year":"2022","unstructured":"Hong EH, Shin YU, Bae GH et al (2022) Ophthalmic complications in retinopathy of prematurity in the first decade of life in Korea using the national health insurance database. Sci Rep 12:1\u20138","journal-title":"Sci Rep"},{"key":"1876_CR24","doi-asserted-by":"publisher","first-page":"18788","DOI":"10.1038\/s41598-022-22338-2","volume":"12","author":"C\u2011Y Huang","year":"2022","unstructured":"Huang C\u2011Y, Lai S\u2011H, Tseng H\u2011J et al (2022) Pulmonary function in school-age children following intravitreal injection of bevacizumab for retinopathy of prematurity. Sci Rep 12:18788","journal-title":"Sci Rep"},{"key":"1876_CR25","first-page":"479","volume":"256","author":"C\u2011Y Huang","year":"2018","unstructured":"Huang C\u2011Y, Lien R, Wang N\u2011K et al (2018) Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurity. Graefe\u2019s Arch Clin Exp Ophthalmol 256:479\u2013487","journal-title":"Clin Exp Ophthalmol"},{"key":"1876_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jaapos.2017.10.006","volume":"22","author":"KA Kennedy","year":"2018","unstructured":"Kennedy KA, Mintz-Hittner HA, and BEAT-ROP Cooperative Group (2018) Medical and developmental outcomes of bevacizumab versus laser for retinopathy of prematurity. J Am Assoc Pediatr Ophthalmol Strabism 22:61\u201365.e1","journal-title":"J Am Assoc Pediatr Ophthalmol Strabism"},{"issue":"0","key":"1876_CR27","first-page":"117","volume":"202","author":"RF Maier","year":"2021","unstructured":"Maier RF, Hummler H, Kellner U et\u00a0al (2021) Guidelines for ophthalmological screening of premature infants in Germany (S2k level, AWMF guidelines register no. 024\/010, March 2020) Joint recommendation of the German Ophthalmological Society (DOG), Retinological Society (RG), Professional Association of Ophthalmologists in Germany e.\u202fV.(BVA), German Society of Paediatrics and Adolescent Medicine (DGKJ), Professional Association of Pediatricians (BVKJ), Federal Association \u201cThe Premature Child\u201d, Society for Neonatology and Paediatric Intensive Care Medicine (GNPI). 118:117\u2013131","journal-title":"AWMF"},{"key":"1876_CR28","first-page":"698","volume":"5","author":"N Marlow","year":"2021","unstructured":"Marlow N, Stahl A, Lepore D et al (2021) 2\u2011year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial. Lancet Child Adolesc Health 5:698\u2013707","journal-title":"Health"},{"key":"1876_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/IAE.0b013e318275394a","volume":"33","author":"MA Mart\u00ednez-Castellanos","year":"2013","unstructured":"Mart\u00ednez-Castellanos MA, Schwartz S, Hern\u00e1ndez-Rojas ML et al (2013) Long-term effect of antiangiogenic therapy for retinopathy of prematurity up to 5 years of follow-up. Retina 33:329\u2013338","journal-title":"Retina"},{"key":"1876_CR30","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","volume":"364","author":"HA Mintz-Hittner","year":"2011","unstructured":"Mintz-Hittner HA, Kennedy KA, Chuang AZ, BEAT-ROP Cooperative Group (2011) Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. New Engl J Med 364:603\u2013615","journal-title":"New Engl J Med"},{"key":"1876_CR31","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/S0161-6420(99)00732-0","volume":"106","author":"HA Mintz-Hittner","year":"1999","unstructured":"Mintz-Hittner HA, Knight-Nanan DM, Satriano DR et al (1999) A small foveal avascular zone may be an historic mark of prematurity. Ophthalmology 106:1409\u20131413","journal-title":"Ophthalmology"},{"key":"1876_CR32","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/jnp.12069","volume":"10","author":"CS Molloy","year":"2016","unstructured":"Molloy CS, Anderson PJ, Anderson VA et al (2016) The long-term outcome of extremely preterm (\u3008 28 weeks\u2019 gestational age) infants with and without severe retinopathy of prematurity. J Neuropsychol 10:276\u2013294","journal-title":"J Neuropsychol"},{"key":"1876_CR33","doi-asserted-by":"crossref","unstructured":"Morin J, Luu TM, Superstein R et al (2016) Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity. Pediatrics 137(4)","DOI":"10.1542\/peds.2015-3218"},{"key":"1876_CR34","doi-asserted-by":"crossref","unstructured":"Natarajan G, Shankaran S, Nolen TL et al (2019) Neurodevelopmental outcomes of preterm infants with retinopathy of prematurity by treatment. Pediatrics 144(2)","DOI":"10.1542\/peds.2018-3537"},{"issue":"2","key":"1876_CR35","first-page":"355","volume":"109","author":"N O\u2019Keeffe","year":"2016","unstructured":"O\u2019Keeffe N, Murphy J, O\u2019Keeffe M et al (2016) Bevacizumab compared with diode laser in stage 3 posterior retinopathy of prematurity: a 5 year follow-up. Irish Med J 109(2):355-355","journal-title":"Irish Med J"},{"key":"1876_CR36","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1001\/archopht.119.8.1110","volume":"119","author":"Cryotherapy for Retinopathy of Prematurity Cooperative Group","year":"2001","unstructured":"Cryotherapy for Retinopathy of Prematurity Cooperative Group (2001) Multicenter trial of cryotherapy for retinopathy of prematurity: ophthalmological outcomes at 10 years. Arch Ophthalmol 119:1110\u20131118","journal-title":"Arch Ophthalmol"},{"key":"1876_CR37","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4103\/sjopt.sjopt_276_21","volume":"36","author":"HB Ozdemir","year":"2022","unstructured":"Ozdemir HB, Ozdek S (2022) Late sequelae of retinopathy of prematurity in adolescence and adulthood. Saudi J Ophthalmology 36:270","journal-title":"Saudi J Ophthalmology"},{"issue":"3","key":"1876_CR38","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/00006982-200406000-00006","volume":"24","author":"KH Park","year":"2004","unstructured":"Park KH, Hwang J\u2011M, Choi MY et al (2004) Retinal detachment of regressed retinopathy of prematurity in children aged 2 to 15 years. Retina 24(3):368\u2013375","journal-title":"Retina"},{"issue":"3","key":"1876_CR39","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0161-6420(92)31968-2","volume":"99","author":"GE Quinn","year":"1992","unstructured":"Quinn GE, Dobson V, Repka MX et al (1992) Development of myopia in infants with birth weights less than 1251\u202fg. Ophthalmology 99(3):329\u2013340","journal-title":"Ophthalmology"},{"key":"1876_CR40","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0161-6420(00)00527-3","volume":"108","author":"GE Quinn","year":"2001","unstructured":"Quinn GE, Dobson V, Siatkowski RM et al (2001) Does cryotherapy affect refractive error?: Results from treated versus control eyes in the cryotherapy for retinopathy of prematurity trial. Ophthalmology 108:343\u2013347","journal-title":"Ophthalmology"},{"key":"1876_CR41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jaapos.2007.09.008","volume":"12","author":"A Ruth","year":"2008","unstructured":"Ruth A, Hutchinson AK, Hubbard G et al (2008) Late vitreous hemorrhage in patients with regressed retinopathy of prematurity. J Am Assoc Pediatr Ophthalmol Strabism 12:181\u2013185","journal-title":"J Am Assoc Pediatr Ophthalmol Strabism"},{"key":"1876_CR42","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.ophtha.2005.12.027","volume":"113","author":"MJ Spirn","year":"2006","unstructured":"Spirn MJ, Lynn MJ, 3rd Baker Hubbard G (2006) Vitreous hemorrhage in children. Ophthalmology 113:848\u2013852","journal-title":"Ophthalmology"},{"issue":"1","key":"1876_CR43","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1111\/aos.14852","volume":"100","author":"A Stahl","year":"2022","unstructured":"Stahl A, Br\u00fcnder MC, Lagr\u00e8ze WA et al (2022) Ranibizumab in retinopathy of prematurity\u2013one-year follow-up of Ophthalmic Outcomes and two-year follow-up of Neurodevelopmental Outcomes from the CARE-ROP study. Acta Ophthalmol 100(1):e91\u2013e99","journal-title":"Acta Ophthalmol"},{"key":"1876_CR44","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1001\/jamapediatrics.2017.4838","volume":"172","author":"A Stahl","year":"2018","unstructured":"Stahl A, Krohne TU, Eter N et al (2018) Comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity: a randomized clinical trial. JAMA Pediatr 172:278\u2013286","journal-title":"JAMA Pediatr"},{"key":"1876_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2011.10.001","author":"MW Stewart","year":"2012","unstructured":"Stewart MW (2012) The expanding role of vascular endothelial growth factor inhibitors in ophthalmology. Mayo Clin Proc. https:\/\/doi.org\/10.1016\/j.mayocp.2011.10.001","journal-title":"Mayo Clin Proc"},{"key":"1876_CR46","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.ajo.2013.05.042","volume":"156","author":"A Sudhalkar","year":"2013","unstructured":"Sudhalkar A, Chhablani J, Jalali S et al (2013) Spontaneous vitreous hemorrhage in children. Am J Ophthalmol 156:1267\u20131271.e2. https:\/\/doi.org\/10.1016\/j.ajo.2013.05.042","journal-title":"Am J Ophthalmol"},{"key":"1876_CR47","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1038\/s41433-019-0500-5","volume":"33","author":"M Takagi","year":"2019","unstructured":"Takagi M, Maruko I, Yamaguchi A et al (2019) Foveal abnormalities determined by optical coherence tomography angiography in children with history of retinopathy of prematurity. Eye 33:1890\u20131896. https:\/\/doi.org\/10.1038\/s41433-019-0500-5","journal-title":"Eye"},{"key":"1876_CR48","doi-asserted-by":"publisher","first-page":"e225643","DOI":"10.1371\/journal.pone.0225643","volume":"14","author":"Q\u2011Q Tan","year":"2019","unstructured":"Tan Q\u2011Q, Christiansen SP, Wang JJPO (2019) Development of refractive error in children treated for retinopathy of prematurity with anti-vascular endothelial growth factor (anti-VEGF) agents: a meta-analysis and systematic review. PLoS One 14:e225643. https:\/\/doi.org\/10.1371\/journal.pone.0225643","journal-title":"PLoS One"},{"issue":"3","key":"1876_CR49","doi-asserted-by":"publisher","first-page":"00088","DOI":"10.1016\/s0021-5155","volume":"0","author":"H Terasaki","year":"2003","unstructured":"Terasaki H, Hirose T (2003) Late-onset retinal detachment associated with regressed retinopathy of prematurity. Jpn J Ophthalmol 47:492\u2013497. https:\/\/doi.org\/10.1016\/s0021-5155(03)00088-1","journal-title":"Jpn J Ophthalmol"},{"key":"1876_CR50","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s00347-020-01112-7","volume":"117","author":"F Treumer","year":"2020","unstructured":"Treumer F, Roider J (2020) Vitreous body hemorrhage\u2014How long can one wait? Ophthalmologe 117:866\u2013870. https:\/\/doi.org\/10.1007\/s00347-020-01112-7","journal-title":"Ophthalmologe"},{"key":"1876_CR51","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1167\/iovs.14-16021","volume":"56","author":"L Vajzovic","year":"2015","unstructured":"Vajzovic L, Rothman AL, Tran-Viet D et al (2015) Delay in retinal photoreceptor development in very preterm compared to term infants. Invest Ophthalmol Vis Sci 56:908\u2013913. https:\/\/doi.org\/10.1167\/iovs.14-16021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1876_CR52","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/ICU.0000000000000786","volume":"32","author":"NG Valikodath","year":"2021","unstructured":"Valikodath NG, Chiang MF, Chan RP (2021) Description and management of retinopathy of prematurity reactivation after intravitreal antivascular endothelial growth factor therapy. Curr Opin Ophthalmol 32:468\u2013474. https:\/\/doi.org\/10.1097\/ICU.0000000000000786","journal-title":"Curr Opin Ophthalmol"},{"key":"1876_CR53","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jaapos.2011.07.017","volume":"15","author":"DK Vanderveen","year":"2011","unstructured":"Vanderveen DK, Bremer DL, Fellows RR et al (2011) Prevalence and course of strabismus through age 6 years in participants of the Early Treatment for Retinopathy of Prematurity randomized trial. J AAPOS 15:536\u2013540. https:\/\/doi.org\/10.1016\/j.jaapos.2011.07.017","journal-title":"J AAPOS"},{"key":"1876_CR54","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00347-018-0701-5","volume":"115","author":"J Walz","year":"2018","unstructured":"Walz J, Bemme S, Reichl S et al (2018) Behandelte Fr\u00fchgeborenenretinopathie in Deutschland. Ophthalmologe 115:476\u2013488. https:\/\/doi.org\/10.1007\/s00347-018-0701-5","journal-title":"Ophthalmologe"},{"key":"1876_CR55","doi-asserted-by":"publisher","first-page":"e744","DOI":"10.1111\/aos.13069","volume":"94","author":"JM Walz","year":"2016","unstructured":"Walz JM, Bemme S, Pielen A et al (2016) The German ROP Registry: data from 90 infants treated for retinopathy of prematurity. Acta Ophthalmol 94:e744\u2013e752. https:\/\/doi.org\/10.1111\/aos.13069","journal-title":"Acta Ophthalmol"},{"key":"1876_CR56","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.ophtha.2012.02.040","volume":"119","author":"W\u2011C Wu","year":"2012","unstructured":"Wu W\u2011C, Lin R\u2011I, Shih C\u2011P et al (2012) Visual acuity, optical components, and macular abnormalities in patients with a history of retinopathy of prematurity. Ophthalmology 119:1907\u20131916. https:\/\/doi.org\/10.1016\/j.ophtha.2012.02.040","journal-title":"Ophthalmology"},{"key":"1876_CR57","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/IAE.0000000000001209","volume":"37","author":"W\u2011C Wu","year":"2017","unstructured":"Wu W\u2011C, Shih C\u2011P, Lien R et al (2017) Serum vascular endothelial growth factor after bevacizumab or ranibizumab treatment for retinopathy of prematurity. Retina 37:694\u2013701. https:\/\/doi.org\/10.1097\/IAE.0000000000001209","journal-title":"Retina"},{"key":"1876_CR58","doi-asserted-by":"publisher","first-page":"e276","DOI":"10.1111\/aos.12053","volume":"91","author":"CS Yang","year":"2013","unstructured":"Yang CS, Wang AG, Shih YF et al (2013) Long-term biometric optic components of diode laser-treated threshold retinopathy of prematurity at 9 years of age. Acta Ophthalmol 91:e276\u2013e282. https:\/\/doi.org\/10.1111\/aos.12053","journal-title":"Acta Ophthalmol"},{"key":"1876_CR59","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1136\/bjophthalmol-2012-301612","volume":"96","author":"SE Yanni","year":"2012","unstructured":"Yanni SE, Wang J, Chan M et al (2012) Foveal avascular zone and foveal pit formation after preterm birth. Br J Ophthalmol 96:961\u2013966. https:\/\/doi.org\/10.1136\/bjophthalmol-2012-301612","journal-title":"Br J Ophthalmol"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-023-01876-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-023-01876-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-023-01876-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T23:35:07Z","timestamp":1729467307000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-023-01876-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,23]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1876"],"URL":"https:\/\/doi.org\/10.1007\/s00347-023-01876-8","relation":{},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,23]]},"assertion":[{"value":"24 April 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.Q.\u00a0Li gibt an, dass kein Interessenkonflikt besteht. J.M.\u00a0Pfeil weist auf folgende Beziehungen hin: Novartis. A.\u00a0Stahl weist auf folgende Beziehungen hin: Allergan, Apellis, Bayer, Novartis, Roche. T.U.\u00a0Krohne weist auf folgende Beziehungen hin: Alimera Sciences, Allergan, Bayer, Heidelberg Engineering, Novartis, Roche.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}